Results 131 to 140 of about 2,414,840 (297)

The Nuclear Receptor Testicular Receptor 4 Orchestrates Cytoskeletal Organization in a G Protein Subunit Alpha 12/Rho‐Associated Protein Kinase–Dependent Manner to Promote Myofibroblast Differentiation and Tissue Fibrosis in Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Members of the superfamily of nuclear receptors have been implicated in inflammatory processes and pathologic tissue remodeling and have emerged as attractive targets for pharmaceutical intervention. However, the role of testicular receptor 4 (TR4; or Nr2c2) in fibroblast activation and rheumatologic diseases has not yet been investigated ...
Yun Zhang   +16 more
wiley   +1 more source

The role of some ADAM-proteins and activation of the insulin growth factor-related pathway in colorectal cancer. [PDF]

open access: yesCent Eur J Immunol, 2018
Walkiewicz K   +3 more
europepmc   +1 more source

ADAM Report #16 (March 1998)

open access: yes, 1998
ADAM REPORT # 16, March 1998 1. Wages and Innovative Clauses 2. Family Friendly Measures in Enterprise Agreements 3.
ACIRRT; Australian Centre for Industrial Relations Research and Training
core  

Complement Activation Linked to Type II Interferon Signaling in Still Disease

open access: yesArthritis &Rheumatology, EarlyView.
Objective Still disease (SD) is an autoinflammatory syndrome characterized by innate immune dysregulation. Although complement can drive inflammation, its involvement in SD remains to be defined. Thus, we aimed to assess complement activation in SD. Methods Complement was assessed using transcriptomic, proteomic, and in vitro approaches. RNA sequencing
Freya M. C. H. Huijsmans   +115 more
wiley   +1 more source

CD248/Endosialin regulates synovial fibroblast state to control coupling of inflammation and bone damage in murine models of immune‐mediated inflammatory arthritis and ageing

open access: yesArthritis &Rheumatology, Accepted Article.
Objective Synovial fibroblasts directly contribute to inflammation and damage in immune‐mediated inflammatory arthritis. CD248/Endosialin is expressed by fibroblasts in the synovium, is highly upregulated during inflammation and has been proposed as a potential therapeutic target.
Samuel Kemble   +12 more
wiley   +1 more source

ADAM Report 4 (November 1994)

open access: yes, 2015
ADAM REPORT # 4, November 1994 1. Features of Registered Agreements 2. The Year in Review 3.
ACIRRT
core  

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló   +5 more
wiley   +1 more source

Adaptive gradient scaling: integrating Adam and landscape modification for protein structure prediction

open access: yesBMC Bioinformatics
Background Protein structure prediction is one of the most important scientific problems, on the one hand, it is one of the NP-hard problems, and on the other hand, it has a wide range of applications including drug discovery and biotechnology ...
Vitalii Kapitan, Michael Choi
doaj   +1 more source

Metabolomic investigation of cisplatin‐induced acute kidney injury in paediatric cancer patients

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Cisplatin causes acute kidney injury (AKI) in approximately 46% of paediatric cancer patients who receive it. Serum creatinine (SCr) is a poor biomarker of cisplatin nephrotoxicity, because there is a delay between cisplatin infusion and SCr elevation.
Yong Jin Lim   +37 more
wiley   +1 more source

Sejarah islam : sejak zaman nabi adam hingga abad xx tahun 2003

open access: yes, 2003
Buku sejarah islam ini membicarakan tentang sejarah masa lampau, sejak zaman nabi adam as. yang diturunkan oleh Allah swt.
Ahmad al-usairy
core  

Home - About - Disclaimer - Privacy